Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Clinical Trial With Randomized, Blinded, Controlled Design to Evaluate the Safety and Immunogenicity of the Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Populations Aged 40 Years and Older Post -Vaccination

NCT06851832 is registered in ClinicalTrials.gov with Ab&B Bio-tech Co., Ltd.JS as lead sponsor.

NCT NCT06851832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06851832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Clinical Trial With Randomized, Blinded, Controlled Design to Evaluate the Safety and Immunogenicity of the Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Populations Aged 40 Years and Older Post -Vaccination
Lead sponsor
Ab&B Bio-tech Co., Ltd.JS
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
February 16, 2025
Completion date
September 16, 2028
Enrollment
960 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, herpes zoster vaccine